Skip to main content
Caplight Logo









BRT Biotechnologies

BRT Biotechnologies

Private
Claremont, CaliforniaHealthcare & Life Scienceshttps://brtbio.com/

Last Round

Seed Round

May 8, 2026

Momentum

Top 50%

of companies Caplight tracks

Company Overview

BRT Biotechnologies is a discovery tools company that operates a platform to generate diverse and high-quality macrocyclic compounds for drug discovery.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

macrocycle drug discoverymacrocyclic compoundsdrug discovery platformmacrocycle librariesundruggable targetscontract research organizationCROhard-to-drug targetsdrug discovery servicesmacrocycle synthesisprotein-protein interactionsPPI inhibitorshit-to-lead optimizationchemical librariesmacrocyclic peptide librariesMCP libraries

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

BRT Biotechnologies Comparables

Compare BRT Biotechnologies with similar companies based on industry and business-model similarity.

BRT Biotechnologies comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Insamo
84%
Curve Therapeutics
84%
Orbis Medicines
81%

BRT Biotechnologies Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Seed RoundMay 8, 2026
AcceleratorOct 26, 2022

Key People

Founding team and executive leadership

Jane Liu

CEO And Co-Founder

Founding Team

BRT Biotechnologies Investors

Notable investors and investment history

BRT Biotechnologies investors
InvestorRounds
StoryHouse VenturesSeed Round

Market signals

Structured signals derived from secondary market and firmographic data.

  • May 8, 2026

    $607K raised in Seed Round.

  • Jan 2, 2026

    Monthly visitors grew 1378% MoM, from 36 to 532.

BRT Biotechnologies Filings

Explore SEC and related filing metadata, where available.

BRT Biotechnologies filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about BRT Biotechnologies's valuation, stock price, and market status.

Is BRT Biotechnologies a public or private company?

BRT Biotechnologies is a private company.

What is the current stock price of BRT Biotechnologies?

BRT Biotechnologies is a private company with no public stock price. No recent secondary market data is available.

How much is BRT Biotechnologies worth (valuation)?

Valuation information for BRT Biotechnologies is not publicly available.

Can I buy BRT Biotechnologies stock?

BRT Biotechnologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was BRT Biotechnologies's last funding round?

BRT Biotechnologies's most recent funding round was Seed Round on May 8, 2026.

Who are the main investors in BRT Biotechnologies?

Investor information for BRT Biotechnologies is not publicly disclosed.

Will BRT Biotechnologies IPO soon?

No public IPO plans have been announced for BRT Biotechnologies.

How can I track BRT Biotechnologies secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor BRT Biotechnologies's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersClaremont, California
Employee Range7
Year Founded2021
Last FundingMay 8, 2026

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?